Artificial intelligence in medicine and the disclosure of risks

被引:46
作者
Kiener, Maximilian [1 ]
机构
[1] Univ Oxford, Fac Philosophy, Queens Coll, High St, Oxford OX1AW, England
基金
欧洲研究理事会;
关键词
Artificial intelligence; Medical disclosure; Risks; Informed consent; COVID-19; ADVERSARIAL ATTACKS; HEALTH-CARE; BLACK-BOX; BIG DATA; ANALYTICS; MANAGE; BIAS;
D O I
10.1007/s00146-020-01085-w
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
This paper focuses on the use of 'black box' AI in medicine and asks whether the physician needs to disclose to patients that even the best AI comes with the risks of cyberattacks, systematic bias, and a particular type of mismatch between AI's implicit assumptions and an individual patient's background situation. Pace current clinical practice, I argue that, under certain circumstances, these risks do need to be disclosed. Otherwise, the physician either vitiates a patient's informed consent or violates a more general obligation to warn him about potentially harmful consequences. To support this view, I argue, first, that the already widely accepted conditions in the evaluation of risks, i.e. the 'nature' and 'likelihood' of risks, speak in favour of disclosure and, second, that principled objections against the disclosure of these risks do not withstand scrutiny. Moreover, I also explain that these risks are exacerbated by pandemics like the COVID-19 crisis, which further emphasises their significance.
引用
收藏
页码:705 / 713
页数:9
相关论文
共 50 条
  • [31] Introduction to Artificial Intelligence and Machine Learning in Pathology and Medicine: Generative and Nongenerative Artificial Intelligence Basics
    Rashidi, Hooman H.
    Pantanowitz, Joshua
    Hanna, Matthew G.
    Tafti, Ahmad P.
    Sanghani, Parth
    Buchinsky, Adam
    Fennell, Brandon
    Deebajah, Mustafa
    Wheeler, Sarah
    Pearce, Thomas
    Abukhiran, Ibrahim
    Robertson, Scott
    Palmer, Octavia
    Gur, Mert
    Tran, Nam K.
    Pantanowitz, Liron
    MODERN PATHOLOGY, 2025, 38 (04)
  • [32] A Scoping Review on the Progress, Applicability, and Future of Explainable Artificial Intelligence in Medicine
    Gonzalez-Alday, Raquel
    Garcia-Cuesta, Esteban
    Kulikowski, Casimir A.
    Maojo, Victor
    APPLIED SCIENCES-BASEL, 2023, 13 (19):
  • [33] Artificial intelligence in family medicine: a scoping review
    Habibi, Amin
    Kalantarion, Masomeh
    Khani, Hamed
    Heidarzadeh, Abtin
    Mohseni, Farzad
    FAMILY MEDICINE AND PRIMARY CARE REVIEW, 2024, 26 (03) : 357 - 382
  • [34] Artificial intelligence in surgical medicine: a brief review
    Guo, Chen
    He, Yutao
    Shi, Zhitian
    Wang, Lin
    ANNALS OF MEDICINE AND SURGERY, 2025, 87 (04): : 2180 - 2186
  • [35] A bibliometric analysis of the advance of artificial intelligence in medicine
    Lin, Mian
    Lin, Lingzhi
    Lin, Lingling
    Lin, Zhengqiu
    Yan, Xiaoxiao
    FRONTIERS IN MEDICINE, 2025, 12
  • [36] CRIMINOLOGICAL RISKS OF USING ARTIFICIAL INTELLIGENCE
    Begishev, Ildar R.
    Khisamova, Zarina I.
    RUSSIAN JOURNAL OF CRIMINOLOGY, 2018, 12 (06): : 767 - 775
  • [37] Artificial Intelligence Risks and Algorithmic Regulation
    Fortes, Pedro Rubim Borges
    Baquero, Pablo Marcello
    Amariles, David Restrepo
    EUROPEAN JOURNAL OF RISK REGULATION, 2022, 13 (03) : 357 - 372
  • [38] Managing the risks of artificial intelligence in agriculture
    Sparrow, Robert
    Howard, Mark
    Degeling, Chris
    NJAS-IMPACT IN AGRICULTURAL AND LIFE SCIENCES, 2021, 93 (01): : 172 - 196
  • [39] The Risks and Challenges of Artificial Intelligence in Endocrinology
    McMahon, Graham T.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (06) : e1468 - e1471
  • [40] Artificial Intelligence Processing and Risks of Discrimination
    Talapina, Elvira, V
    PRAVO-ZHURNAL VYSSHEI SHKOLY EKONOMIKI, 2022, (01): : 4 - 27